BIOMAT Database Logo BIOMAT Database Logo

[Serum hepatitis from the viewpoint of Au-SH antigen studies]. 1971

F Wewalka

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007565 Jaundice A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. Icterus,Jaundice, Hemolytic,Hemolytic Jaundice,Hemolytic Jaundices,Jaundices, Hemolytic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009339 Needles Sharp instruments used for puncturing or suturing. Hypodermic Needles,Hypodermic Needle,Needle,Needle, Hypodermic,Needles, Hypodermic
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Wewalka
[Au-SH-antigen and hepatitis].
August 1970, Deutsche medizinische Wochenschrift (1946),
F Wewalka
[Animal anti-serum for the determination of hepatitis associated antigen (Au-SH-Antigen)].
December 1970, Klinische Wochenschrift,
F Wewalka
[Study of the presence of Au antigen (serum hepatitis, SH antigen) and antibodies against Au antigen in donor and patient serum].
January 1971, Nederlands tijdschrift voor geneeskunde,
F Wewalka
[Importance of the hepatitis associated antigen (Au-SH)].
November 1971, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
F Wewalka
Au-SH antigen, hepatitis, and polyarteritis nodosa.
January 1971, Progress in immunobiological standardization,
F Wewalka
[New viewpoints in the prevention of transfusion-induced serum hepatitis (Au-SH-Antigen)].
August 1971, Wiener klinische Wochenschrift,
F Wewalka
[Quantitative determination of Australia (Au-SH) antigen and the clinical course of serum hepatitis].
March 1972, Klinische Wochenschrift,
F Wewalka
[The Australia-Au-SH--antigen, hepatitis, and other diseases].
November 1972, Orvosi hetilap,
F Wewalka
Australia antigen and serum hepatitis. A prospective study of the frequency of serum hepatitis after transfusion of Au-SH-antigen positive blood units.
April 1972, American journal of diseases of children (1960),
F Wewalka
The purification of hepatitis-associated antigen (HAA-SH-AU) from human serum and the preparation of a sheep anti-HAA serum.
January 1972, Vox sanguinis,
Copied contents to your clipboard!